These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32017680)

  • 21. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.
    Huntsman RJ; Tang-Wai R; Alcorn J; Vuong S; Acton B; Corley S; Laprairie R; Lyon AW; Meier S; Mousseau DD; Newmeyer D; Prosser-Loose E; Seifert B; Tellez-Zenteno J; Huh L; Leung E; Major P
    Front Neurol; 2019; 10():716. PubMed ID: 31333569
    [No Abstract]   [Full Text] [Related]  

  • 25. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
    Ryan D; Drysdale AJ; Pertwee RG; Platt B
    Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic role of Cannabidiol in mental health: a systematic review.
    Khan R; Naveed S; Mian N; Fida A; Raafey MA; Aedma KK
    J Cannabis Res; 2020 Jan; 2(1):2. PubMed ID: 33526132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of oral cannabis extracts in children with epilepsy.
    Knupp KG; Rice JD; Helmkamp LJ; Galinkin J; Sempio C; Jost K; Chapman KE
    Seizure; 2019 Nov; 72():23-27. PubMed ID: 31550641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of Cannabis Findings in the Hair of Very Young Children: Mission Impossible.
    Kintz P; Ameline A; Eibel A; Gheddar L; Feisthauer E; Geraut A; Berthelon L; Farrugia A; Raul JS
    Curr Pharm Biotechnol; 2017; 18(10):791-795. PubMed ID: 29189142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Central Effect of Components of Cannabis: Utility and Risk].
    Mishima K; Irie K
    Yakugaku Zasshi; 2020; 140(2):193-204. PubMed ID: 32009043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.
    Tzadok M; Uliel-Siboni S; Linder I; Kramer U; Epstein O; Menascu S; Nissenkorn A; Yosef OB; Hyman E; Granot D; Dor M; Lerman-Sagie T; Ben-Zeev B
    Seizure; 2016 Feb; 35():41-4. PubMed ID: 26800377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marijuana Use in Epilepsy: The Myth and the Reality.
    Detyniecki K; Hirsch L
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
    Allendorfer JB; Szaflarski JP
    Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.